Geode Capital Management
BCYC

Geode Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

Geode Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.7K Sell
19,035
-6,094
-24% -$27.9K ﹤0.01% 4141
2026
Q1 		$117K Hold
25,129
– – ﹤0.01% 4094
2025
Q4 		$178K Sell
25,129
-14,796
-37% -$109K ﹤0.01% 3946
2025
Q3 		$309K Sell
39,925
-487
-1% -$3.68K ﹤0.01% 3790
2025
Q2 		$281K Buy
40,412
+19,035
+89% +$152K ﹤0.01% 3762
2025
Q1 		$181K Sell
21,377
-17,438
-45% -$205K ﹤0.01% 3877
2024
Q4 		$543K Buy
38,815
+480
+1% +$10.3K ﹤0.01% 3573
2024
Q3 		$868K Buy
38,335
+16,958
+79% +$391K ﹤0.01% 3405
2024
Q2 		$433K Hold
21,377
– – ﹤0.01% 3619
2024
Q1 		$532K Buy
21,377
+2,540
+13% +$54K ﹤0.01% 3591
2023
Q4 		$341K Buy
18,837
+1,693
+10% +$28K ﹤0.01% 3748
2023
Q3 		$344K Hold
17,144
– – ﹤0.01% 3758
2023
Q2 		$438K Hold
17,144
– – ﹤0.01% 3695
2023
Q1 		$365K Hold
17,144
– – ﹤0.01% 3776
2022
Q4 		$507K Sell
17,144
-4,276
-20% -$115K ﹤0.01% 3652
2022
Q3 		$498K Buy
21,420
+10,287
+92% +$245K ﹤0.01% 3728
2022
Q2 		$186K Hold
11,133
– – ﹤0.01% 4308
2022
Q1 		$488K Buy
11,133
+1,253
+13% +$58.5K ﹤0.01% 3944
2021
Q4 		$601K Hold
9,880
– – ﹤0.01% 3947
2021
Q3 		$410K Buy
9,880
+2,401
+32% +$84K ﹤0.01% 4126
2021
Q2 		$227K Buy
+7,479
New +$226K ﹤0.01% 4293

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management's BCYC Position: Q2 2026 in Review

Geode Capital Management reduced its Bicycle Therapeutics (BCYC) stake by 24% in Q2 2026, selling an estimated $27.9K and leaving 19,035 shares worth $80.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4141.

Geode Capital Management first reported a position in BCYC in Q2 2021 and has held it in 21 quarters since. The position peaked at $868K in Q3 2024. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Geode Capital Management held 19,035 shares of Bicycle Therapeutics worth $80.7K as of Q2 2026.
  • Geode Capital Management sold 6,094 Bicycle Therapeutics shares in Q2 2026, an estimated $27.9K.
  • Bicycle Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4141 holding.
  • Geode Capital Management first reported a position in Bicycle Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Bicycle Therapeutics position peaked at $868K in Q3 2024.
  • 104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.